The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Athira Pharma, Inc(NASDAQ:ATHA) 
 
 
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and stop neurodegradation. Its lead product candidate is ATH-1017, a blood brain barrier-penetrating, small hepatocyte growth factor/MET activator that is in LIFT-AD...
Website: http://www.athira.com
Founded: 2011
CEO: Leen Kawas  
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Athira Pharma Days Payable Outstanding ttm (DPO)
Athira Pharma Op Cashflow Per Share ttm
Athira Pharma Free Cashflow Per Share ttm
Athira Pharma Cash Per Share ttm
Athira Pharma (GAAP) P/E ratio ttm
Athira Pharma P/B ratio ttm
No extra charts and metrics for this ticker.
